Trial intelligence / Profile preview

Acetylsalicylic acid as secondary prevention after liver resection for colorectal cancer liver metastases

2014-003601-15Phase 2Completed

Sponsor
Oslo University Hospital
Start
Dec 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in colorectal cancer (CRC) comparing Trombyl (aspirin) arm with Placebo arm (2 arms). Primary endpoint: Disease-free survival (DFS). Started Dec 2017; status: completed.

02

Drugs

aspirin
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on 2014-003601-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003601-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call